Skip to main content
SpringerLink
Log in

Bone turnover in hyperthyroidism before and after thyrostatic management

  • Original Article
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

Hyperthyroidism is associated with enhanced osteoblastic and osteoclastic activity, and patients frequently have low bone mineral density and high bone turnover. The aim of this study was to examine the bone formation and resorption markers trend in 12 female patients, before and after normalization of thyroid activity. The following measurements were made at baseline and 1 and 6 months after hormone normalization induced by methimazole treatment: total alkaline phosphatase (ALP), bone alkaline phosphatase (BALP), collagen type C-terminal propeptide (PICP), osteocalcin (BGP), telopeptide (ICTP), urinary-hydroxyproline/ urinary creatinine (uOHP/uCreat), urinary calcium/urinary creatinine (uCa/uCreat) and deoxypyridinoline crosslinks (D-Pyr). Compared with controls, all of these parameters were significantly increased (ALP p=0.014; BALP p=0.0001; PICP p=0.013; BGP p=0.009; ICTP p=0.0001; uOHP/uCreat p=0.002; uCa/uCreat p=0.044; crosslinks p=0.0001). After treatment the values of ALP, BALP and PICP in hyperthyroid patients showed an initial slight increase and then a significant downwards trend (ALP p=0.008, BAP p= 0.001, PICP p=0.026). Furthermore, resorption markers showed a significant decrease (uOHP/ uCreat p<0.005 and D-Pyr p<0.008). As regards lumbar BMD patients, measurements were significantly reduced in comparison with the control group (p=0.005). Six months after serum thyroid hormones level normalization, we observed a significant increase (p=0.014 vs baseline). Both neo-formation and resorption markers are useful to assess pathological bone turnover and bone involvement in hyperthyroidism. They could also be employed to monitor the effect of antithyroid treatment on bone and to indicate if bone antiresorption therapy should be considered.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Melsen F., Heriksen E.F., Charles P. Morphometric and dynamic studies of bone change in hyperthyroidism. Acta Pathol. Microbiol. Scand. 1977, 85: 141–150.

    Google Scholar 

  2. Meunier P.J., Bianchi G.G.S., Edouard C.M., Bernard J., Courpron P., Vignon G. Bony manifestations of thyreotoxicosis. Orthop. Clin. North Am. 1972, 3: 745–774.

    Google Scholar 

  3. Riggs B.L., Melton III L.J. Involutional osteoporosis. N. Engl. J. Med. 1990, 314: 1676–1686.

    Article  Google Scholar 

  4. Baran D.T., Braverman L.E. Editorial: Thyroid hormones and bone mass. J. Clin. Endocrinol. Metab. 1991, 72: 1182–1183.

    Article  CAS  PubMed  Google Scholar 

  5. Grant D.J., Marion E.T., McMurdo M.E., Mole P.A., Paterson C.R. Is previous hyperthyroidism still a risk factor for osteoporosis in post-menopausal women? Clin. Endocrinol. 1995, 43: 339–345.

    Article  CAS  Google Scholar 

  6. Bauer D.C., Cummings S.R., Tao J.L., Browner W.S., SOFR Group. Hyperthyroidism increases the risk of hip fracture. A prospective study. J. Bone Miner. Res. 1992, 7: S121 (Abstract no. 166).

    Google Scholar 

  7. Rosen C.J., Adler R.A. Longitudinal changes in lumbar bone density in thyrotoxic patients after attainement of euthyroidism. J. Clin. Endocrinol. Metab. 1992, 75: 1531–1534.

    CAS  PubMed  Google Scholar 

  8. Lalau J.D., Sebert J.L., Marie A., Fournier A., Quichaud J. Effect of thyreotoxicosis and its treatment on mineral and bone metabolism. J. Endocrinol. Invest. 1996, 9: 491–496.

    Article  Google Scholar 

  9. Siddiqi A., Burrin J.M., Nooan K., James I., Wood D.F., Price C.P. A longitudinal study of markers of bone turnover in Graves’ disease and their value in predicting bone mineral density. J. Clin. Endocrinol. Metab. 1997, 82: 753–759.

    CAS  PubMed  Google Scholar 

  10. Oikawa M., Kushida K., Takahashi M., Ohishi T., Hoshino H., Suzuki M., Ogihara H., Ishigaki J., Inoue T. Bone turnover and cortical bone mineral density in the distal radius in patients with hyperthyroidism being treated with antithyroid drugs for various periods of time. Clin. Endocrinol. 1999, 50: 171–176.

    Article  Google Scholar 

  11. Mundy G.R., Shapiro J.L., Baudelin J.C., Canalis E. M., Raisz L.G. Direct stimulation of bone resorption by thyroid hormones. J. Clin. Invest. 1976, 58: 529–534.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  12. Marcus R. Cyclic nucleotide phosphodiesterase from bone: characterization of the enzyme and studies of inhibition by thyroid hormones. Endocrinology 1975, 96: 400–408.

    Article  CAS  PubMed  Google Scholar 

  13. Mundy G.R., Luben R.A., Raisz L.G., Oppenheim J.J., Buell D.M. Bone resorbing activity in supernatants of lymphoid cell lines. N. Engl. J. Med. 1974, 290: 867–871.

    Article  CAS  PubMed  Google Scholar 

  14. Gowen M., Wood D.D., Ihrie E.F., McGuire M.K.B., Russel G.G. An interleukin-like factor stimulates bone resorption in vitro. Nature 1983, 306: 378–380.

    Article  CAS  PubMed  Google Scholar 

  15. Moselkilde L., Eriksen, E.F., Charles P. Effects of thyroid hormones on bone and mineral metabolism. Endocrinol. Metab. Clin. North Am. 1990, 19: 35–63.

    Google Scholar 

  16. Siddiqi A., Monson J.P., Wood F., Besser G.M., Burrin J.M. Serum cytokines in thyrotoxicosis. J. Clin. Endocrinol. Metab. 1999, 84: 435–439.

    CAS  PubMed  Google Scholar 

  17. Siddiqi A., Burrin J.M., Wood D.F., Monson J.P. T3 regulates the production of IL-6 and IL-8 in human bone marrow stromal and osteoblast-like cells. J. Endocrinol. 1998, 157: 453–461.

    Article  CAS  PubMed  Google Scholar 

  18. Lee M.S., Kim K.Y., Lee M.C., Cho B.Y., Lee H.K., Koch C.S., Min H.K. Negative correlation between the change in bone mineral density and serum osteocalcin in patients with hyperthyroidism. J. Clin. Endocrinol. Metab. 1990, 70: 766–770.

    Article  CAS  PubMed  Google Scholar 

  19. Mc.Leod J.M., Mc.Hardy K.C., Harvey R.D., Duncan A., Reid I.W., Bewsher P.D., Robin S.P. The early effects of radioiodine therapy for hyperthyroidism on biochemical indices of bone turnover. Clin. Endocrinol. (Oxf.) 1993, 38: 49–53.

    Article  Google Scholar 

  20. Rizzoli R., Poser J., Bargi U. Nuclear thyroid hormone receptors in cultured bone cells. Metabolism 1986, 35: 71–74.

    Article  CAS  PubMed  Google Scholar 

  21. Harvey R.D., Mc.Hardy K. C., Reid I.W., Paterson F., Beusher P.D., Duncan A., Robins S.P. Measurement of bone collagen degradation in hyperthyroidism and during thyroxine replacement therapy using pyridinium cross-links as specific urinary markers. J. Clin. Endocrinol. Metab. 1991, 72: 1189–1194.

    Article  CAS  PubMed  Google Scholar 

  22. Garnero P., Vassy B., Bertholin A., Riou J.P., Delmas P.D. Markers of bone turnover in hyperthyroidism and the effects of treatment. J. Clin. Endocrinol. Metab. 1994, 78: 955–959.

    CAS  PubMed  Google Scholar 

  23. Mosekilde L., Melsen F. Effect of antithyroid treatment on calcium-phosphorus metabolism in hyperthyroidism. II: Bone histomorphometry. Acta Endocrinol. 1978, 87: 751–758.

    CAS  PubMed  Google Scholar 

  24. Minisola S., Pacitti M.T., Romagnoli E., Rosso R., Carnevale V., Caravella P., Scillitani A., Dicembrino F. Clinical validation of a new immunoradiometric assay for intact human osteocalcin. Calcif. Tissue Int. 1999, 64: 365–469.

    Article  CAS  PubMed  Google Scholar 

  25. Hannon R., Blumsohn A., Naylor K., Eastell R. Response of biochemical markers of bone turnover to hormone replacement therapy: impact of biological variability. J. Bone Miner. Res. 1998, 7: 1124–1132.

    Article  Google Scholar 

  26. Jodar E., Munoz-Torres M., Escobar-Jimenez F., Quesada M., Luna J., Olea N. Antiresorptive therapy in hyperthyroid patients: longitudinal changes in bone and mineral metabolism. J. Clin. Endocrinol. Metab. 1997, 82: 1989–1994.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine, University of Turin, Corso A.M. Dogliotti 14, 10126, Torino, Italy

    Giancarlo Isaia, C. Roggia, D. Gola, M. Di Stefano, P. Ardissone & M. Mussetta

  2. Endocrinology Division, Ospedale Mauriziano, Turin, Italy

    G. Gallone

  3. Baldi e Riberi Laboratory, Azienda Ospedaliera San Giovanni Battista, Turin, Italy

    G. Aimo

Authors
  1. Giancarlo Isaia
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C. Roggia
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. D. Gola
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M. Di Stefano
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. G. Gallone
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. G. Aimo
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. P. Ardissone
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. M. Mussetta
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Isaia, G., Roggia, C., Gola, D. et al. Bone turnover in hyperthyroidism before and after thyrostatic management. J Endocrinol Invest 23, 727–731 (2000). https://doi.org/10.1007/BF03345061

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03345061

Key-words

Search

Navigation